跳至主要内容
临床试验/NL-OMON55511
NL-OMON55511招募中不适用

COlon Capsule Endoscopy as an AlterNative for CT-colonography in Colorectal Cancer Screening - The OCEAN Trial

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Participation in the Dutch national CRC screening programme
  • 2. Positive result on FIT screening
  • 3. Contra-indications to undergo colonoscopy or sedation OR
  • 4. Not willing to undergo colonoscopy OR
  • 5. Prior incomplete colonoscopy

排除标准

  • 1. Inability or refusal to provide informed consent
  • 2. Persons with a severe or terminal disease with a life-expectancy of less
  • than 5 years
  • 3. An allergy or any other known contraindication to the medication used in
  • 4. Renal failure, eGFR <30 ml/min/1.73m2
  • 5. Congestive heart failure NYHA class III or IV
  • 6. Dysphagia or other swallowing disorder which makes it impossible to swallow
  • the capsule
  • 7. High risk of capsule retention: IBD, personal history of gastrointestinal
  • surgery other than uncomplicated procedures that would be unlikely to lead to
  • bowel obstruction based on the clinical judgment of the investigator
  • 8. Cardiac pacemakers or other implanted electro-medical equipment
  • 9. An MRI scheduled within 14 days after ingestion of the capsule
  • 10. Patients with diagnosed or suspected Congenital Long QT Syndrome
  • 11. Patients with high risk concomitant use of drugs that prolong the QT
  • interval. The risk should be based on the concerning medication in combination
  • with the dosages and should be evaluated based on the clinical judgement of the
  • investigator.
  • 12. Patients with manifest hyperthyroidism
  • 13. Patients with an allergy or hypersensitivity for iodinated agents

研究者

相似试验